SDGR实时信号 | 通过Getagraph.com最大化利润

出售 111891 min ago

@ $26.72

发出时间: 14 Feb 2024 @ 04:43

回报率: -5.39%

上一信号: Feb 14 - 03:54

上一信号: 购买

回报率: 0.26 %

Live Chart Being Loaded With Signals

Commentary (1 May 2024 @ 21:34):

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications...

Stats
今日成交量	32 304.00
平均成交量	867 539
市值	1.84B
EPS	$0 ( 2024-02-28 )
下一个收益日期	( $-0.760 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	46.81
ATR14	$0.0290 (0.11%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-21	Abel Robert Lorne	Buy	30 000	Stock Option (right to buy)
2024-03-21	Lorton Kenneth Patrick	Buy	30 000	Stock Option (right to buy)
2024-03-06	Lorton Kenneth Patrick	Buy	5 574	Common Stock
2024-03-06	Lorton Kenneth Patrick	Sell	5 574	Stock Option (right to buy)
2024-03-04	Porges Geoffrey Craig	Buy	90 000	Stock Option (right to buy)

INSIDER POWER
76.91
Last 97 transactions
Buy: 2 214 027 \| Sell: 335 407

音量相关性

長: 0.37 (neutral)

短: -0.77 (moderate negative)

Signal:(90.235) Neutral

Schrodinger Inc 相关性

10 最正相关
RDUS	0.853
KZIA	0.834
VCXA	0.809

10 最负相关
SFST	-0.85
SPWR	-0.819
SBBP	-0.817

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Schrodinger Inc 相关性 - 货币/商品

0.23
( neutral )

-0.43
( neutral )

0.18
( neutral )

0.52
( weak )

-0.16
( neutral )

Schrodinger Inc 财务报表

Annual	2023
营收:	$216.67M
毛利润:	$140.11M (64.66 %)
EPS:	$0.570

FY	2023
营收:	$216.67M
毛利润:	$140.11M (64.66 %)
EPS:	$0.570

FY	2022
营收:	$180.96M
毛利润:	$101.02M (55.83 %)
EPS:	$-2.10

FY	2021
营收:	$137.93M
毛利润:	$65.62M (47.57 %)
EPS:	$-1.430

Financial Reports:

No articles found.

Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

实时更新： Schrodinger Inc [SDGR]

Upcoming Earnings Alert